LaSalle St. Investment Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

LaSalle St. Investment Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Buy	6,947 +1	+0%	+$51	0.04%	297
2026 Q1	$371K	Buy	6,946 +1	+0%	+$59	0.05%	260
2025 Q4	$431K	Buy	6,945 +901	+15%	+$55.6K	0.07%	212
2025 Q3	$363K	Buy	+6,044	New	+$370K	0.07%	220
2025 Q2	–	Sell	-6,068	Closed	-$365K	–	334
2025 Q1	$365K	Buy	+6,068	New	+$377K	0.09%	186
2023 Q2	–	Sell	-3,711	Closed	-$200K	–	129
2023 Q1	$200K	Sell	3,711 -302	-8%	-$16.1K	0.09%	121
2022 Q4	$210K	Buy	+4,013	New	+$204K	0.1%	91

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LaSalle St. Investment Advisors's IHI Position: Q2 2026 in Review

LaSalle St. Investment Advisors increased its iShares US Medical Devices ETF (IHI) stake by 0.01% in Q2 2026, buying an estimated $51 and bringing the position to 6,947 shares worth $343K. The position accounts for 0.04% of the portfolio, ranked #297.

LaSalle St. Investment Advisors first reported a position in IHI in Q4 2022 and has held it in 7 quarters since. The position peaked at $431K in Q4 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

LaSalle St. Investment Advisors held 6,947 shares of iShares US Medical Devices ETF worth $343K as of Q2 2026.
LaSalle St. Investment Advisors bought 1 iShares US Medical Devices ETF share in Q2 2026, an estimated $51.
iShares US Medical Devices ETF made up 0.04% of LaSalle St. Investment Advisors's portfolio in Q2 2026, its #297 holding.
LaSalle St. Investment Advisors first reported a position in iShares US Medical Devices ETF in Q4 2022 and has held it in 7 quarters since.
LaSalle St. Investment Advisors's iShares US Medical Devices ETF position peaked at $431K in Q4 2025.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.